CD39 Regulation and Functions in T Cells

被引:82
|
作者
Timperi, Eleonora [1 ]
Barnaba, Vincenzo [2 ,3 ]
机构
[1] PSL Res Univ, Inst Curie, Dept Immunol, INSERM,U932, 26 Rue Ulm, F-75005 Paris, France
[2] Sapienza Univ Roma, Dept Internal Clin Sci Anaesthesiol & Cardiovasc, I-00161 Rome, Italy
[3] Ist Pasteur Italia, Fdn Cenci Bolognetti, I-00161 Rome, Italy
关键词
adenosine; CD39; CD73; regulatory T cells; conventional CD4(+) T cells; CD8(+) T cells; single nucleotide polymorphism; targeting therapy; TUMOR-GROWTH; ECTONUCLEOTIDASES CD39; ADENOSINE RECEPTORS; EXTRACELLULAR ATP; EXPRESSION; CD73; CANCER; INHIBITION; ANTIBODY; A2A;
D O I
10.3390/ijms22158068
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD39 is an enzyme which is responsible, together with CD73, for a cascade converting adenosine triphosphate into adenosine diphosphate and cyclic adenosine monophosphate, ultimately leading to the release of an immunosuppressive form of adenosine in the tumor microenvironment. Here, we first review the environmental and genetic factors shaping CD39 expression. Second, we report CD39 functions in the T cell compartment, highlighting its role in regulatory T cells, conventional CD4(+) T cells and CD8(+) T cells. Finally, we compile a list of studies, from preclinical models to clinical trials, which have made essential contributions to the discovery of novel combinatorial approaches in the treatment of cancer.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Immune-regulation of CD39 on Regulatory T cells
    Siddiqui, Shafiuddin
    Da Cunha, Andre Pires
    Weiner, Howard L.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 165 - 166
  • [2] Regulation of the T Cell Response by CD39
    Takenaka, Maisa C.
    Robson, Simon
    Quintana, Francisco J.
    [J]. TRENDS IN IMMUNOLOGY, 2016, 37 (07) : 427 - 439
  • [3] Regulatory T cells and CD39 expression in transplantation
    Dwyer, Karen
    Robson, Simon
    [J]. PURINERGIC SIGNALLING, 2010, 6 : 26 - 26
  • [4] ACTIVATION OF CD4(+)CD39(+) T CELLS IN COLORECTAL CANCER
    Zhulai, G. A.
    Churov, A., V
    Oleinik, E. K.
    Romanov, A. A.
    Semakova, P. N.
    Oleinik, V. M.
    [J]. BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2018, (03): : 47 - 53
  • [5] Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
    Shevchenko, Ivan
    Mathes, Andreas
    Groth, Christopher
    Karakhanova, Svetlana
    Mueller, Verena
    Utikal, Jochen
    Werner, Jens
    Bazhin, Alexandr V.
    Umansky, Viktor
    [J]. ONCOIMMUNOLOGY, 2020, 9 (01):
  • [6] CD39 is a novel surface marker of murine regulatory T cells
    Dwyer, Karen
    Deaglio, Silvia
    Gao, Wenda
    Strom, Terry
    Robson, Simon
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03): : A28 - A29
  • [7] CD39: A new surface marker of mouse regulatory γδ T cells
    Otsuka, Atsushi
    Hanakawa, Sho
    Miyachi, Yoshiki
    Kabashima, Kenji
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (06) : 1448 - 1451
  • [8] CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
    Gupta, Prakash K.
    Godec, Jernej
    Wolski, David
    Adland, Emily
    Yates, Kathleen
    Pauken, Kristen E.
    Cosgrove, Cormac
    Ledderose, Carola
    Junger, Wolfgang G.
    Robson, Simon C.
    Wherry, E. John
    Alter, Galit
    Goulder, Philip J. R.
    Klenerman, Paul
    Sharpe, Arlene H.
    Lauer, Georg M.
    Haining, W. Nicholas
    [J]. PLoS Pathogens, 2015, 11 (10)
  • [9] CD39 Expression in Mesenchymal Stromal Cells
    Saldanha-Araujo, Felipe
    Panepucci, Rodrigo A.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2011, 34 (07) : 568 - 568
  • [10] The use of CD39 as a marker for functional regulatory T cells in multiple sclerosis
    Fletcher, Jean M.
    Lonergan, Roisin
    Costelloe, Lisa
    O'Farrelly, Cliona
    Tubridy, Niall
    Mills, Kingston H.
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S123 - S123